Delivery Order SPE2DB24D2205-SPE2DB25FDTCG

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $7,384.68, with a completion date of September 16, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines to the Defense Logistics Agency (DLA). The contract, valued at $12,592.80, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,592.80 and an ultimate completion date of November 14, 2024. It is a firm fixed price delivery order contract. The award is not associated with a...
This federal contract award is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product to the Defense Logistics Agency (DLA). The contract, awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office division, has a ceiling value of $7,431.64 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant single-award Indefinite...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2023, with a ceiling value of $29,286.50 and a completion date of February 27, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award is for the procurement of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $108,043.14 and an ultimate completion date of May 15, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical vaccine product. The award, with a ceiling value of $4,495.66, is a firm fixed-price delivery order contract with an ultimate completion date of August 6, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, as the prime contractor, will be...
This federal contract award is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $6,153.90 and is a Firm Fixed Price Delivery Order with a period of performance through April 3, 2024. The contract does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,910.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of July 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $35,256.15, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 3, 2024. The contract is not designated as a set-aside and was competitively...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,442.50 firm fixed price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTCG
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which is a vaccine. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $10,120.35 and has an ultimate completion date of October 25, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/23/25, 9:10 AM